SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16280697
Source:
http://linkedlifedata.com/resource/pubmed/id/16280697
Search
Subject
(
78
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0001554
,
umls-concept:C0008976
,
umls-concept:C0021756
,
umls-concept:C0034380
,
umls-concept:C0348016
,
umls-concept:C0443315
,
umls-concept:C0887947
pubmed:issue
4
pubmed:dateCreated
2005-11-10
pubmed:abstractText
To assess the impact of subcutaneous and intravenous interleukin-2 (IL-2) on health-related quality of life (HRQOL) in adults with HIV-1 receiving highly active antiretroviral therapy (HAART).
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/AI-25859
,
http://linkedlifedata.com/resource/pubmed/grant/AI-25868
,
http://linkedlifedata.com/resource/pubmed/grant/AI-25879
,
http://linkedlifedata.com/resource/pubmed/grant/AI-25903
,
http://linkedlifedata.com/resource/pubmed/grant/AI-25924
,
http://linkedlifedata.com/resource/pubmed/grant/AI-27658
,
http://linkedlifedata.com/resource/pubmed/grant/AI-27659
,
http://linkedlifedata.com/resource/pubmed/grant/AI-27660
,
http://linkedlifedata.com/resource/pubmed/grant/AI-27661
,
http://linkedlifedata.com/resource/pubmed/grant/AI-27663
,
http://linkedlifedata.com/resource/pubmed/grant/AI-27665
,
http://linkedlifedata.com/resource/pubmed/grant/AI-27666
,
http://linkedlifedata.com/resource/pubmed/grant/AI-27668
,
http://linkedlifedata.com/resource/pubmed/grant/AI-27673
,
http://linkedlifedata.com/resource/pubmed/grant/AI-27767
,
http://linkedlifedata.com/resource/pubmed/grant/AI-32770
,
http://linkedlifedata.com/resource/pubmed/grant/AI-32775
,
http://linkedlifedata.com/resource/pubmed/grant/AI-32782
,
http://linkedlifedata.com/resource/pubmed/grant/AI-34853
,
http://linkedlifedata.com/resource/pubmed/grant/AI-36219
,
http://linkedlifedata.com/resource/pubmed/grant/AI-38844
,
http://linkedlifedata.com/resource/pubmed/grant/AI-39156
,
http://linkedlifedata.com/resource/pubmed/grant/AI-46370
,
http://linkedlifedata.com/resource/pubmed/grant/AI-46386
,
http://linkedlifedata.com/resource/pubmed/grant/AI-50410
,
http://linkedlifedata.com/resource/pubmed/grant/RR-00046
,
http://linkedlifedata.com/resource/pubmed/grant/RR-00047
,
http://linkedlifedata.com/resource/pubmed/grant/RR-00052
,
http://linkedlifedata.com/resource/pubmed/grant/RR-00865
,
http://linkedlifedata.com/resource/pubmed/grant/RR-05096
,
http://linkedlifedata.com/resource/pubmed/grant/U01 AI-38858
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/100892005
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1525-4135
pubmed:author
pubmed-author:Adult AIDS Clinical Trials Group
,
pubmed-author:GelmanRebeccaR
,
pubmed-author:MartinBarbara KBK
,
pubmed-author:MitsuyasuRonald TRT
,
pubmed-author:WuAlbert WAW
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
40
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
428-33
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:16280697-Acquired Immunodeficiency Syndrome
,
pubmed-meshheading:16280697-Adult
,
pubmed-meshheading:16280697-Antiretroviral Therapy, Highly Active
,
pubmed-meshheading:16280697-Drug Therapy, Combination
,
pubmed-meshheading:16280697-Humans
,
pubmed-meshheading:16280697-Injections, Intravenous
,
pubmed-meshheading:16280697-Injections, Subcutaneous
,
pubmed-meshheading:16280697-Interleukin-2
,
pubmed-meshheading:16280697-Quality of Life
pubmed:year
2005
pubmed:articleTitle
Quality of life in a clinical trial of highly active antiretroviral therapy alone or with intravenous or subcutaneous interleukin-2 administration.
pubmed:affiliation
The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. bmartin@jhsph.edu
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Research Support, N.I.H., Extramural